Email address
[email protected]Contact number
+44 20 7379 0000Chambers Review
Gowling WLG's sterling commercial life sciences practice is recommended for complex licence, research and collaboration agreements. The firm is excellent for corporate and investment transactions involving spin-offs. It also recognised for biotech and pharmaceutical patent litigation including disputes involving applications for SPCs, and draws on the firm's international presence to provide life sciences expertise across multiple jurisdictions.
Work Highlights
- Gowling WLG represented Isomorphic Labs in its research collaboration with Eli Lilly todiscover small molecule drugs against multiple targets using AI.
Strengths
Provided by Chambers
"Gowling is a go-to. The team is very approachable and pragmatic."
"The Gowling lawyers quickly grasp complex research collaboration concepts. They are up to date with current activities in this industry and have excellent current awareness."
"Gowling is a go-to. The team is very approachable and pragmatic."
"The Gowling lawyers quickly grasp complex research collaboration concepts. They are up to date with current activities in this industry and have excellent current awareness."
Notable Practitioners
Patrick Duxbury is known for his deft handling of complex technology transfer, research and collaboration agreements, indeed all manner of IP-driven transactions. He is a go-to for many of the sector's top companies.
"Patrick is very experienced and very knowledgeable of other deals in his past and in the market. He always brings that experience to bear."
"Patrick is easy to deal with and incredibly calm in difficult circumstances."
"Patrick is very knowledgable in all areas and provides an excellent service."
Luke Kempton advises corporates and research institutes on all manner of development, collaboration and licence agreements. He counts domestic and international life science companies among his clients.
Paul Inman is commended for his work as a patent litigator in cases concerning biotech, medical devices and pharmaceuticals. He has additional experience in chemical patents indirect to life sciences treatments, such as refrigerants.
"Paul has strong litigation practice."